To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction

NCT00526253 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

BIOLOGICAL: MyoCell
BIOLOGICAL: MyoCell
PROCEDURE: Hypothermosol

Sponsor

Bioheart, Inc.